Aqueous and Ethanolic Valeriana officinalis Extracts Change the Binding of Ligands to Glutamate Receptors

被引:14
作者
Del Valle-Mojica, Lisa M. [1 ]
Cordero-Hernandez, Jose M. [1 ]
Gonzalez-Medina, Giselle [1 ]
Ramos-Velez, Igmeris [1 ]
Berrios-Cartagena, Nairimer [1 ]
Torres-Hernandez, Bianca A. [1 ]
Ortiz, Jose G. [1 ]
机构
[1] Univ Puerto Rico, Sch Med, Dept Pharmacol & Toxicol, San Juan, PR 00936 USA
关键词
VALERENIC ACID; GABA(A) RECEPTORS; DOUBLE-BLIND; IN-VITRO; SLEEP; 6-METHYLAPIGENIN; IDENTIFICATION; DERIVATIVES; TRANSPORT; ANXIETY;
D O I
10.1155/2011/891819
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
The effects of two valerian extracts (aqueous and hydroalcoholic) were investigated through [H-3] Glutamate ([H-3] Glu) and [H-3] Fluorowillardine ([H-3] FW) receptor binding assays using rat synaptic membranes in presence of different receptor ligands. In addition, the extract stability was monitored spectrophotometrically. Both extracts demonstrated interaction with ionotropic glutamate receptors (iGluRs). However, the extracts displayed considerable differences in receptor selectivity. The hydroalcoholic extract selectively interacted with quisqualic acid (QA), group I metabotropic glutamate receptor (mGluR) ligand, while the aqueous extract did not alter the binding of QA. The stability of the extracts was examined during several weeks. Freshly prepared extract inhibited 38-60% of [H-3] FW binding (AMPA). After 10 days, the aqueous extract inhibited 85% of [H-3] FW binding while the hydroalcoholic extract markedly potentiated (200%) [H-3] FW binding to AMPA receptors. Thus, our results showed that factors such as extraction solvent and extract stability determine the selectivity for glutamate receptor (GluR) interactions.
引用
收藏
页数:7
相关论文
共 41 条
[1]   Effect of valepotriates (valerian extract) in generalized anxiety disorder: a randomized placebo-controlled pilot study [J].
Andreatini, R ;
Sartori, VA ;
Seabra, MLV ;
Leite, JR .
PHYTOTHERAPY RESEARCH, 2002, 16 (07) :650-654
[2]   GABAA receptors as in vivo substrate for the anxiolytic action of valerenic acid, a major constituent of valerian root extracts [J].
Benke, Dietmar ;
Barberis, Andrea ;
Kopp, Sascha ;
Altmann, Karl-Heinz ;
Schubiger, Monika ;
Vogt, Kaspar E. ;
Rudolph, Uwe ;
Moehler, Hanns .
NEUROPHARMACOLOGY, 2009, 56 (01) :174-181
[3]   Vaterian for steep: A systematic re view and meta-anatysis [J].
Bent, Stephen ;
Padula, Amy ;
Moore, Dan ;
Patterson, Michael ;
Mehling, Woff .
AMERICAN JOURNAL OF MEDICINE, 2006, 119 (12) :1005-1012
[4]  
Bos R, 1996, PHYTOCHEM ANALYSIS, V7, P143, DOI 10.1002/(SICI)1099-1565(199605)7:3<143::AID-PCA284>3.0.CO
[5]  
2-1
[6]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[7]  
CAVADAS C, 1995, ARZNEIMITTELFORSCH, V45, P753
[8]  
Chojnacka-Wojcik E, 2001, Curr Opin Investig Drugs, V2, P1112
[9]   Biological and analytical characterization of two extracts from Valeriana officinalis [J].
Circosta, Clara ;
De Pasquale, Rita ;
Samperi, Stefania ;
Pino, Annalisa ;
Occhiuto, Francesco .
JOURNAL OF ETHNOPHARMACOLOGY, 2007, 112 (02) :361-367
[10]   A double-blind, placebo-controlled investigation of the effects of two doses of a valerian preparation on the sleep, cognitive and psychomotor function of sleep-disturbed older adults [J].
Diaper, A ;
Hindmarch, I .
PHYTOTHERAPY RESEARCH, 2004, 18 (10) :831-836